Evaluation of the role of autophagy in acute myeloid leukaemic cell differentiation

Simple item page
dc.check.embargoformatNot applicableen
dc.check.infoNo embargo requireden
dc.check.opt-outYesen
dc.check.reasonNo embargo requireden
dc.check.typeNo Embargo Required
dc.contributor.advisorCahill, Maryen
dc.contributor.advisorMongan, Nigelen
dc.contributor.advisorGudas, Lorraineen
dc.contributor.advisorMcKenna, Sharon L.en
dc.contributor.authorOrfali, Nina
dc.date.accessioned2017-06-19T11:19:48Z
dc.date.available2017-06-19T11:19:48Z
dc.date.issued2017
dc.date.submitted2017
dc.description.abstractAcute myeloid leukemia (AML) is a malignancy characterized by the accumulation of white blood cell precursors in the bone marrow and circulation. Treatment regimens for this disease are notoriously toxic and survival is poor. Pharmacological overcoming the differentiation block seen in AML is an attractive avenue of therapy, termed ‘differentiation therapy’. The best example of this is the use of all-trans-retinoic acid (ATRA) in the treatment of acute promyelocytic leukaemia (APL). The differentiation of APL cells treated with ATRA in vitro is a model that allows the examination of differentiation pathways in myeloid leukaemic cells. Using this principle, my thesis examines the activity during differentiation, of two pathways involved in post-translational protein handling - autophagy and ISGylation. Autophagy is an intracellular recycling pathway responsible for degrading aged or redundant proteins. I demonstrate that ATRA induces autophagy and this has a functional role in differentiation. Autophagy inhibition reduces myeloid differentiation while pharmacologic induction may promote differentiation in ATRA-resistant cells. Using next-generation sequencing, I explore the molecular communication between retinoids and autophagy and study the expression changes in autophagy-related genes occurring in ATRAtreated APL cells. I also demonstrate that ISGylation is activated during differentiation, a process regulating the addition of a ubiquitin-like modifier, interferonstimulated gene 15 (ISG15) to target proteins. Targeted inhibition of ISGylation impedes differentiation. I discuss the benefits and practical implications of pharmacologically targeting both autophagy and ISGylation. A thorough molecular understanding of these pathways might broaden the application of differentiation therapy to other AML subtypes.en
dc.description.statusNot peer revieweden
dc.description.versionAccepted Version
dc.format.mimetypeapplication/pdfen
dc.identifier.citationOrfali, N. 2017. Evaluation of the role of autophagy in acute myeloid leukaemic cell differentiation. PhD Thesis, University College Cork.en
dc.identifier.urihttps://hdl.handle.net/10468/4089
dc.language.isoenen
dc.publisherUniversity College Corken
dc.rights© 2017, Nina Orfali.en
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/en
dc.subjectAutophagyen
dc.subjectDifferentiationen
dc.subjectISGylationen
dc.subjectAcute myeloid leukaemiaen
dc.thesis.opt-outtrue
dc.titleEvaluation of the role of autophagy in acute myeloid leukaemic cell differentiationen
dc.typeDoctoral thesisen
dc.type.qualificationlevelDoctoralen
dc.type.qualificationnamePhD (Medicine and Health)en
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Thesis Abstract.pdf
Size:
283.98 KB
Format:
Adobe Portable Document Format
Description:
Thesis Abstract
License bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
license.txt
Size:
5.62 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Thumbnail Image
Name:
Nina Orfali.pdf
Size:
27.21 KB
Format:
Adobe Portable Document Format
Description:
Opt-Out Form
Collections
Doctoral Theses
College of Medicine and Health - Doctoral Theses
Medicine - Doctoral Theses